Chemoinformaics analysis of ferulic acid ester
| Molecular Weight | 602.9 | nRot | 8 |
| Heavy Atom Molecular Weight | 544.436 | nRig | 31 |
| Exact Molecular Weight | 602.434 | nRing | 6 |
| Solubility: LogS | -7.094 | nHRing | 0 |
| Solubility: LogP | 9.319 | No. of Aliphatic Rings | 5 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
| Atoms Count | 102 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 44 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 5 |
| No. of Hydrogen atom | 58 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 40 | No. of Saturated Rings | 5 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
| nHA | 4 | APOL | 108.682 |
| nHD | 1 | BPOL | 62.526 |
| QED | 0.183 |
| Synth | 5.54 |
| Natural Product Likeliness | 2.682 |
| NR-PPAR-gamma | 0.931 |
| Lipinski | Rejected |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.977 |
| Pgp-sub | 0.001 |
| HIA | 0.003 |
| CACO-2 | -5.019 |
| MDCK | 0.0000194 |
| BBB | 0.017 |
| PPB | 0.97951 |
| VDSS | 2.605 |
| FU | 0.0256928 |
| CYP1A2-inh | 0.044 |
| CYP1A2-sub | 0.264 |
| CYP2c19-inh | 0.238 |
| CYP2c19-sub | 0.906 |
| CYP2c9-inh | 0.165 |
| CYP2c9-sub | 0.901 |
| CYP2d6-inh | 0.56 |
| CYP2d6-sub | 0.786 |
| CYP3a4-inh | 0.75 |
| CYP3a4-sub | 0.715 |
| CL | 9.067 |
| T12 | 0.028 |
| hERG | 0.952 |
| Ames | 0.003 |
| ROA | 0.112 |
| SkinSen | 0.968 |
| Carcinogencity | 0.046 |
| EI | 0.044 |
| Respiratory | 0.897 |
| NR-Aromatase | 0.572 |
| Antiviral | Yes |
| Prediction | 0.794958 |